Glycomine

1 follower


Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.

Industries

Employees

11-50

Links


Org chart

Steven Axon
Director & CEO
Collapse
Hicham Alaoui
Chief Scientific Officer
Geoffrey Hird
Chief Technology Officer
Peter McWilliams
Chief Business Officer
Emily Tess
Chief of Staff, Director of Corporate Development & Strategy
Colette Muenzen
Senior Legal Consultant
Rose Marino
Chief Medical Officer

Board & advisors